EP1305025 - PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND A 5-PHENOXYALKYL-2,4-THIAZOLIDINEDIONE-TYPE DERIVATIVE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.06.2005 Database last updated on 19.10.2024 | Most recent event Tooltip | 17.06.2005 | Application deemed to be withdrawn | published on 03.08.2005 [2005/31] | Applicant(s) | For all designated states Merck Patent GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | [N/P] |
Former [2003/18] | For all designated states MERCK PATENT GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | Inventor(s) | 01 /
MOINET, Gérard 15, rue Lamartine F-91400 Orsay / FR | 02 /
BOTTON, Gérard 9bis, rue du Haras F-78530 Buc / FR | 03 /
MESANGEAU, Didier 5 rue Auguste Renoir F-77380 Combs La Ville / FR | [2003/18] | Application number, filing date | 01960539.3 | 24.07.2001 | [2003/18] | WO2001EP08512 | Priority number, date | FR20000010362 | 04.08.2000 Original published format: FR 0010362 | [2003/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0211721 | Date: | 14.02.2002 | Language: | EN | [2002/07] | Type: | A1 Application with search report | No.: | EP1305025 | Date: | 02.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.02.2002 takes the place of the publication of the European patent application. | [2003/18] | Search report(s) | International search report - published on: | EP | 14.02.2002 | Classification | IPC: | A61K31/425, A61P7/00, // A61K31:425, A61K31:155 | [2003/18] | CPC: |
A61K31/425 (EP,US);
A61K31/426 (KR);
A61P3/10 (EP);
A61P7/00 (EP);
A61P7/12 (EP)
| C-Set: |
A61K31/425, A61K2300/00 (US,EP);
A61K31/425, A61K31/155 (EP,US) | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/18] | Extension states | AL | Not yet paid | LT | 06.12.2002 | LV | 06.12.2002 | MK | Not yet paid | RO | 06.12.2002 | SI | 06.12.2002 | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND METFORMIN UND EIN 5-PHENOXYALKYL-2,4-THIAZOLIDINDION-TYP DERIVAT | [2003/18] | English: | PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND A 5-PHENOXYALKYL-2,4-THIAZOLIDINEDIONE-TYPE DERIVATIVE | [2003/18] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA METFORMINE ET UN DERIVE DE TYPE 5-PHENOXYALKYLE-2,4-THIAZOLIDINEDIONE | [2003/18] | Entry into regional phase | 06.12.2002 | National basic fee paid | 06.12.2002 | Designation fee(s) paid | 06.12.2002 | Examination fee paid | Examination procedure | 13.02.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.12.2002 | Examination requested [2003/18] | 01.02.2005 | Application deemed to be withdrawn, date of legal effect [2005/31] | 07.03.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2005/31] | Fees paid | Renewal fee | 14.07.2003 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2004 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]WO9857634 (SMITHKLINE BEECHAM PLC [GB], et al) [DA] 1,2,5 * claims 1-3 * * page 2, lines 25-30 *; | [A]WO9903477 (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1,2,5 * claims 1,3,13 *; | [A] - M.RIDDLE, "Combining sulfonylureas and other agents", AMERICAN JOURNAL OF MEDICINE, (2000), vol. 108, no. suppl. 6A, pages 15S - 22S, XP001002376 [A] 1,2,5 * page 15S * * page 16S * DOI: http://dx.doi.org/10.1016/S0002-9343(00)00338-7 |